What the FDA Actually Evaluated in Seven Peptides: The July 2026 Compounding Committee Record
FDA staff said no to all seven peptides; the PCAC advised six. Our matrix of 343 cited references: uses, human data, votes, authorship and status. v1.0.
-
-
Flmodafinil and Fladrafinil on the 2026 WADA Prohibited List
WADA named flmodafinil and fladrafinil under class S6 in 2026. Why it adds examples rather than a new ban, and what it means for confirmatory analysis.
-
What the FDA Is About to Debate on Peptide Impurities, Sameness and Manufacturing
The FDA and CRCG hold a two-day workshop on the generic GLP-1 pathway on 23 and 24 September 2026. The agenda names every point at which two peptides with identical sequences stop being the same medicine.
-
Research Use Only Is Not a Regulatory Shield: What the FDA’s 2026 Peptide Warning Letters Actually Say
The FDA published five warning letters to research-peptide sellers on 1 September 2026. All five rest on website review alone, and the agency states directly that research-use-only labelling did not displace the evidence of intended human use.
-
Why a Generic Peptide Is Harder Than a Generic Pill: Inside FDA’s July 2026 Guidance Revision
FDA revised 17 product-specific guidances for generic peptides and withdrew its 2021 synthetic peptide guidance. The five areas it targeted explain why the same amino acid sequence does not guarantee the same drug.
-
A “Research Use Only” Label Is Not a Legal Status: What FDA and Lilly Established in 2026
FDA set aside an RUO disclaimer and ruled on the rest of the website instead. Lilly then asked payment processors and carriers to cut off sellers. Together they define how this sector is now assessed.
-
Is Tesofensine Legal in Europe? Regulatory Status (2026)
Tesofensine has no EMA marketing authorisation and is not an EU-scheduled controlled substance — but it remains an unapproved investigational compound. The 2026 regulatory picture, from primary EU records.
-
Which Research Compounds Are Legal in Europe? A 2026 Status Matrix
There is no single legal status for research compounds in Europe — it depends on the molecule and, above all, on what it is sold and used as. Across the compounds Condor Research supplies, the pattern is consistent: almost none hold an EU medicine authorisation, most are not authorised foods or supplements, and several (the…
-
Is CJC-1295 Legal in Europe? EMA & WADA 2026 Status
Is CJC-1295 legal in Europe? It has never been authorised as a medicine anywhere in the world and is explicitly named on the WADA 2026 Prohibited List. An honest, source-cited look at what its RUO status actually means.
-
Is Ipamorelin Legal in Europe? EMA Status & WADA 2026
Is ipamorelin legal in Europe? It holds no EMA authorisation, was abandoned after Phase II trials, and is explicitly named on the WADA 2026 Prohibited List. An honest, source-cited look at what ‘legal’ actually means for a compound with no approved human use anywhere in the world.
